WASHINGTON - Kidney Cancer Research Alliance (KCCure) President Dena Battle has been elected to the National Cancer Institute’s Renal Task Force to serve as one of two patient advocates on the panel.
Keith M Puls (1958-2017) was diagnosed May 2017 with stage IV RCC. Keith and I began this journey scared and anxious. We fought hard and this disease was very powerful and overwhelming. Keith was an amazing chef, artist, and musician
Register today to learn more about how to apply for new kidney cancer funding! Kidney cancer research funding will be provided for the fiscal year 2017 (FY17) through a new, $10 million, stand-alone program in the Department of Defense Congressionally Directed Medical Research Programs.
KCCure's Kidney Cancer Research Priorities were developed in response to a survey conducted for the newly formed Kidney Cancer Research Program (KCRP). Advice and suggestions were gathered from our National Patient Advisory Board and our Scientific Advisory Board.
The Kidney Cancer Research Alliance (KCCure) is offering a $100,000 research grant for a pilot project focused on cutting-edge, innovative scientific research in kidney cancer.
My unique combination makes me a lab rat for my oncologists, and that's okay— I hope that my story will help everyone impacted by Tuberous Sclerosis Complex and Renal Cell Carcinoma.
KCCure talks with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Comprehensive Cancer Center in Washington, DC about the TIVO-3 trial and what it means for kidney cancer patients.